Intrinsic Value of S&P & Nasdaq Contact Us

Fresenius SE & Co. KGaA FSNUY OTC

Other OTC • Healthcare • Medical - Care Facilities • DE • USD

SharesGrow Score
53/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$9.30
-29.8%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Fresenius SE & Co. KGaA (FSNUY) trades at a trailing P/E of 94.6, forward P/E of 14.4. Trailing earnings yield is 1.06%, forward earnings yield 6.94%. PEG 0.57 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (12/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 94.6); analyst consensus target implies downside from the current price ($9.30, 29.8%).
  • Forward P/E 14.4 (down from trailing 94.6) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.57 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 1.06% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 6.94% as earnings recover.
  • Analyst consensus target $9.30 (-29.8% downside) — analysts see meaningful downside risk at the current price level.

Overall SharesGrow Score: 53/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
53/100
SG Score
View full scorecard →
VALUE
12/100
Price-to-Earnings & upside
Proven by this page
FUTURE
64/100
Analyst consensus
→ Forecast
~
PAST
75/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
65/100
→ Income
~
GROWTH
58/100
→ Income
~
INCOME
45/100
→ Income

Valuation Snapshot — FSNUY

Valuation Multiples
P/E (TTM)94.6
Forward P/E14.4
PEG Ratio0.57
Forward PEG0.03
P/B Ratio0.00
P/S Ratio5.43
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.14
Forward EPS (Est.)$0.92
Book Value / Share$0.00
Revenue / Share$2.44
FCF / Share$0.00
Yields & Fair Value
Earnings Yield1.06%
Forward Earnings Yield6.94%
Dividend Yield0.00%
Analyst Target$9.30 (-29.8%)

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $0.71 $29.08B $1.59B 5.5%
2017 $0.81 $33.89B $1.81B 5.4%
2018 $0.91 $33.53B $2.03B 6%
2019 $0.85 $35.41B $1.88B 5.3%
2020 $0.77 $36.28B $1.71B 4.7%
2021 $0.82 $37.52B $1.82B 4.8%
2022 $0.61 $40.84B $1.37B 3.4%
2023 $-0.07 $22.3B $-594M -2.7%
2024 $0.05 $21.83B $471M 2.2%
2025 $0.14 $21.97B $1.21B 5.5%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message